Holt-Oram syndrome (HOS) is a rare autosomal dominant disorder. This syndrome is so called Heart and Hand Syndrome. We report a case of prenatal diagnosis of HOS by sonographic findings. A 29-year-old Japanese multiparous woman was introduced to our tertiary medical centre at pregnancy 30 weeks and 3 days of gestation for further examination of fetal bilateral upper limb abnormalities and congenital heart disease (CHD). She had no significant past medical history and no history of consanguinity or genetic disorders on either side of families. Sonographic findings showed at a bilateral ectodactyly, radial deviation of the wrist, multiple muscular and perimembranous ventricular and atrial septal defects (VSD and ASD) and a persistent left superior vena cava with sinus bradycardia. Other no major anomaly was not found. After genetic counselling, she underwent amniocentesis at 33 weeks 2 days of gestation. Amniotic fluid cell karyotyping revealed normal female karyotype. According to absent of bilateral thumb, an underdeveloped humerus and CHD, we prenatally suspected HOS. At 41 weeks and 1 day of gestation, a 2922 g female was delivered vaginally. On physical examination of the infant, right upper limb had radially bowed forearm, radial deviation of the wrist (a deformity that is caused by absence of the radius) associated with flexion deformity at the elbow and wrist joint, and ectodactyly. Left upper limb had shortened mid segment, stiff fingers and ectodactyly. Radiological examination showed bilateral radial dysplasia with complete absence of right radius and thumb, and absence of left radius and thumb, index finger and hypoplasia of left humerus. Echocardiography confirmed muscular and perimembranous VSD, large secundum ASD, and persistent left superior vena cava draining into dilated coronary sinus with sinus bradycardia. Because of mutations in the TBX5 genes associated from her lymphocyte and typical features, HOS was diagnosed. The Conradi-Hünermann-Happle syndrome or Dominant X-Linqued Chondrodysplasia Punctata (CDPX2) is a rare genetic syndrome characterised by dermatological, ocular and skeletal manifestations. A diagnostic approach can be performed with the ultrasound in the prenatal period, however, it is confirmed by a physical examination of classic manifestation and genetic test. It's treatment is multidisciplinary and focused on each alteration it presents, as there is no definitive treatment. This clinical case study is of a pregnant patient with a family history and a genetic diagnosis of the Conradi syndrome. The preliminary diagnosis was performed by doing a pre-natal ultrasound showing skeletal alterations characteristic of this syndrome, later on this diagnostic were confirmed when the child was born and a physical examination was performed as well as. With this clinical case, we can conclude that the ultrasound is reliable to suspect the pre-natal diagnosis in those patients with a history of the disease and to be able to investigate the different manifestation of this pathology.
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Gestational age estimator based on MRI data: a user-friendly graphical user interface Methods: The data base provided by Kline-Fath et al which contain a look up table including the previously estimated gestational age and the measured indices was used as the base of estimations in the software. The Caretta Software, GUI Design Studio was used for programming. This software let the user to generate interactive prototypes without writing a code. Results: The GA will be estimated just in two steps using this software. At the first page the user can select the index of interest which was measured on the MRI image. Another page will open and the measured value should be entered and simply the estimated gestational age will be appeared on the page. Conclusions: This software can be very helpful in reducing the GA estimation time and besides it partially eliminates the human error.
Supporting information can be found in the online version of this abstract
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The prediction study of fetal growth restriction with universal third trimester ultrasonic measurements and Doppler parameters C. Zhu, Y. Ren
Ultrasound, Obstetrics and Gynecology, Hospital of Fudan University, Shanghai, China
Objectives: Fetal growth restriction (FGR) is associated with increased fetal and neonatal mortality and morbidity, which can lead to immediate perinatal adverse events. However, effective options to predict FGR still lack of consensus, and need more studies to follow. We aim at achieving the efficacy of the evaluation of ultrasound fetal growth measurements and Doppler parameters to predict FGR. Methods: Case-control study within a prospective cohort of singleton pregnancies for third trimester was enrolled. Women accepted ultrasound examination every 4 weeks from 28 to 41 weeks. Growth measurements including BPD, HC, AC and FL were recorded for this study. Doppler parameters, such as UA-PI, MCA-PI and MCA-PSVmom were analysed. Meanwhile, we calculated each measure Zscore with INTERGROWTH-21st fetal growth standards form. We set up predictive models within fetal growth values Zscore to predict FGR and adverse perinatal outcome(APO). Control group(BW≥10th%) and FGR group (BW<10th%) were settled as two groups. APO was defined as the presence of non-reassuring fetal status requiring emergent Caesarean, 5-minute Apgar score<7', neonatal metabolic acidosis at birth or stillbirth. Results: A total of 834 patients fulfilling the inclusion criteria were included. After the exclusion of 143 lost cases, 565 cases of Control group and 126 cases of FGR group were obtained. Among them, 33 neonates have an adverse perinatal outcome. We established a model with the measures Zscore predict FGR and APO. Its accuracy was higher than INTERGROWTH-21st EFW Zscore. However, the performance of the model was similar to that obtained by measures Zscore combined with Doppler indices was significant contributors to the prediction of FGR and APO. Conclusions: The use of measures Z-score provides a good prediction for FGR and APO in the general population. Meanwhile, UA-PI and MCA-PI combined with measures predict APO of some significance. woman was randomly selected to include 1,000 events. Exclusion criteria: maternal or fetal morbidity, or with estimated fetal weight above the 90 or below the 10 percentile. A mean and standard deviation for the renal artery (RA) peak systolic velocity (RAPSV), RA resistance index (RARI), RA pulsatility index (RAPI) and RA systolic diastolic ratio (RASDR) were derived for each week of gestation from 20 through 40 weeks. Second-degree polynomials for all regressions. The log transformation provided the best normalisation as determined by visual assessment of the values. 
